09/ 18/ 2026
FDA Publishes 55 Draft Product-Specific Guidances, Further Refining Pathways for Complex Generic Drug Development
FDA’s latest 55 draft PSGs further clarify generic drug development, with continued focus on complex products and science-based BE approaches.
09/ 17/ 2026
Jinan Mayor Yu Haitan Visits Bestcomm Pharma to Learn About R&D and Innovation
Jinan Mayor Yu Haitan visited Bestcomm Pharma to learn about its pharmaceutical R&D capabilities, innovation platforms, and business development.
09/ 16/ 2026
Bestcomm Pharma Successfully Holds Its 15th Annual Sports Meeting
Bestcomm Pharma’s 15th Annual Sports Meeting brought employees together through competition, teamwork, and a shared commitment to health and vitality.
